Your session is about to expire
← Back to Search
Immunomodulator
Beta Alethine for Multiple Myeloma
Phase 1 & 2
Waitlist Available
Research Sponsored by LifeTime Pharmaceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Histologically proven myeloma
No clinical signs or evidence of active brain involvement or leptomeningeal disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is studying beta alethine to see how well it works in treating patients with myeloma.
Who is the study for?
This trial is for adults with myeloma who are not pregnant or nursing, have a good performance status, and no history of alcoholism, drug addiction, or psychotic disorders. They must have measurable disease markers and their major organs need to function well. People can't join if they've had recent cancer treatments, solid organ transplants, significant heart issues, active infections or HIV/AIDS.Check my eligibility
What is being tested?
The study is testing the effectiveness of beta alethine—a biological therapy aimed at stimulating the immune system to fight myeloma cells. It's in Phase I/II which means it's early in testing but also looking at how well it works as a treatment.See study design
What are the potential side effects?
Potential side effects aren't specified here but generally biological therapies like beta alethine could cause flu-like symptoms (fever, chills), fatigue, weakness and sometimes allergic reactions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My diagnosis of myeloma is confirmed through tissue examination.
Select...
My cancer has not spread to my brain or its coverings.
Select...
My kidneys are working well.
Select...
My smoldering myeloma is worsening but hasn't affected my bones.
Select...
I have a single myeloma tumor.
Select...
My blood condition is worsening, with changes in protein levels or red blood cell count.
Select...
I am 18 years old or older.
Select...
I can perform most of my daily activities without assistance.
Select...
I do not have uncontrolled heart problems.
Select...
I do not have AIDS.
Select...
I do not have any ongoing infections or fistulas.
Select...
I am not currently taking any corticosteroids.
Select...
I haven't had radiation on more than 25% of my bone marrow.
Select...
I have not had any organ transplant surgeries.
Select...
I am not taking any drugs that weaken my immune system.
Select...
I am not taking any anti-inflammatory medications, including aspirin.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
LifeTime PharmaceuticalsLead Sponsor
2 Previous Clinical Trials
Suzin Mayerson, PhDStudy ChairLifeTime Pharmaceuticals
2 Previous Clinical Trials
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My diagnosis of myeloma is confirmed through tissue examination.My cancer has not spread to my brain or its coverings.My kidneys are working well.My myeloma is slow-growing with gradual bone changes.I do not have uncontrolled heart problems.I do not have AIDS.I do not have any ongoing infections or fistulas.I have been diagnosed with multiple myeloma.My smoldering myeloma is worsening but hasn't affected my bones.I have a single myeloma tumor.My blood condition is worsening, with changes in protein levels or red blood cell count.My condition is slow-growing and doesn't need treatment right now.I am 18 years old or older.I can perform most of my daily activities without assistance.I don't have any other serious illnesses that would stop me from joining the study.It has been over 4 weeks since my last immunotherapy or cytokine treatment.It has been over 4 weeks since my last chemotherapy.I am not currently taking any corticosteroids.I haven't had radiation on more than 25% of my bone marrow.I have fully recovered from my previous surgery.I have not had any organ transplant surgeries.I am not taking any drugs that weaken my immune system.I am not taking any anti-inflammatory medications, including aspirin.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are we currently enrolling participants for this research?
"No, this particular clinical trial is not currently seeking patients. However, it is worth noting that the study was originally posted on 8/1/2000 and updated as recently as 12/17/2013. Additionally, there are 855 other trials which are actively looking for participants."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger